fam83h Antibody

What is FAM83H and why is it significant for research?

FAM83H is a protein that plays a major role in the structural organization and calcification of developing dental enamel. It also functions in keratin cytoskeleton organization by recruiting casein kinase I (CK-1) to keratin filaments, thereby regulating epithelial cell migration. The significance of FAM83H lies in its critical role in amelogenesis, as mutations in the FAM83H gene cause amelogenesis imperfecta (AI), a genetic disorder affecting enamel formation . The protein is expressed in ameloblasts and epidermal germinative cells, making it an important target for studying tooth development, cytoskeletal organization, and related disorders .

Which species reactivity should be considered when selecting a FAM83H antibody?

When selecting a FAM83H antibody, researchers should consider that commercially available antibodies like the rabbit polyclonal FAM83H antibody (ab121816) have been validated for reactivity with human, mouse, and rat samples . This cross-reactivity is due to sequence homology across these species. For other species, researchers should evaluate sequence homology to predict potential reactivity. It's essential to validate the antibody in your specific experimental system, especially if working with unconventional model organisms or specialized cell lines .

What are the typical applications for FAM83H antibodies in research?

FAM83H antibodies are primarily used in:

• Western blot (WB) analysis - typically detecting a band around 127 kDa in mammalian cell lysates such as MCF7 (human), NIH/3T3 (mouse), and NBT-II (rat)

• Immunohistochemistry on paraffin-embedded sections (IHC-P) - for examining FAM83H expression in tissues like skin, stomach, duodenum, and skeletal muscle

• Immunofluorescence - for studying subcellular localization of wild-type vs. mutant FAM83H proteins

• Validation of knockdown/knockout models - confirming successful manipulation of FAM83H expression in functional studies

• Investigating protein-protein interactions - particularly with casein kinase I and keratin cytoskeletal components

How should antigen retrieval be optimized for FAM83H detection in IHC-P?

For optimal FAM83H detection in IHC-P applications, heat-mediated antigen retrieval with citrate buffer at pH 6 is recommended based on validated protocols . This approach effectively unmasks the FAM83H epitopes while preserving tissue architecture. Researchers should consider the following methodological steps:

• Use freshly prepared citrate buffer at pH 6.0

• Perform heat-mediated retrieval (95-100°C) for 15-20 minutes

• Allow gradual cooling to room temperature

• Optimize antibody dilution (starting at 1/20 concentration is recommended based on published work)

• Include positive control tissues (epithelial tissues like skin are suitable controls)

• Consider dual staining with keratin markers to confirm localization patterns, as FAM83H shows preferential localization to keratin filaments

Inadequate antigen retrieval is a common cause of false negative results when studying FAM83H.

What are the recommended controls when studying FAM83H expression in experimental models?

To ensure robust and reproducible results when studying FAM83H expression, researchers should implement the following control measures:

Positive controls:

• Known FAM83H-expressing cells (e.g., MCF7 human breast adenocarcinoma cells)

• Epithelial tissues (skin, stomach, duodenum)

• Ameloblasts or ameloblastoma cells (for dental research)

Negative controls:

• Primary antibody omission

• Isotype control antibody

• FAM83H knockdown/knockout samples (experimentally created)

• Non-epithelial tissues or cells with minimal FAM83H expression

Specificity controls:

• Pre-absorption with immunizing peptide

• Detection of consistent band size (127 kDa) in Western blot applications

• Assessment of subcellular localization patterns (cytoplasmic distribution for wild-type FAM83H)

These comprehensive controls help distinguish true FAM83H signal from background or non-specific staining.

How do I design experiments to study FAM83H mutations and their effect on protein function?

When designing experiments to study FAM83H mutations and their functional consequences, consider this methodological framework:

• Construct generation

  • Create expression vectors containing wild-type FAM83H and clinically relevant mutants (e.g., truncation mutations like p.Glu659Ter)

  • Include epitope tags (if needed) that won't interfere with protein function

• Expression system selection

  • Use relevant cell types (ameloblasts, epithelial cells, or ameloblastoma cell lines)

  • Consider stable vs. transient transfection based on experimental timeline

• Functional assessments

  • Protein localization: Compare wild-type (typically cytoplasmic) vs. mutant (often nuclear) localization using immunofluorescence

  • Keratin cytoskeleton organization: Evaluate effects on keratin filament structure

  • Desmosome formation: Assess localization of desmosomal proteins to cell-cell junctions

  • Protein-protein interactions: Investigate interaction with casein kinase I (CK-1)

• Molecular manipulation

  • Use CK-1 inhibitors like D4476 to evaluate the relationship between FAM83H and CK-1

  • Employ RNA interference to create knockdown models for comparison

• Expression analysis

  • Measure both mRNA (real-time RT-PCR) and protein expression (Western blot)

  • Account for potential discrepancies between mRNA and protein levels (as observed with some mutants)

This comprehensive approach allows for detailed characterization of how FAM83H mutations impact protein function at multiple levels.

How can I resolve discrepancies between FAM83H mRNA and protein expression levels?

Discrepancies between FAM83H mRNA and protein levels have been reported, particularly with mutant variants. For example, research has shown that certain FAM83H mutations can reduce mRNA expression while increasing protein expression . To investigate and resolve such discrepancies:

• Parallel quantification

  • Measure mRNA using RT-qPCR with multiple reference genes for normalization

  • Quantify protein using Western blot with appropriate loading controls

  • Derive mRNA-to-protein ratios from the same biological samples

• Protein stability assessment

  • Conduct cycloheximide chase experiments to compare protein half-life between wild-type and mutant FAM83H

  • Inhibit various degradation pathways (proteasomal, lysosomal) to identify differences in protein turnover

• Translational efficiency analysis

  • Perform polysome profiling to assess translational status of FAM83H mRNA

  • Consider ribosome footprinting to measure translation efficiency directly

• Post-transcriptional regulation

  • Investigate miRNA-mediated regulation using prediction tools and functional validation

  • Assess mRNA stability using actinomycin D chase experiments

• Confounding factors

  • Check for alternative splicing events that might affect detection

  • Ensure antibody epitopes are preserved in mutant proteins

  • Validate findings in multiple cell types to rule out cell-specific effects

These methodological approaches help elucidate the molecular mechanisms underlying discrepant mRNA/protein expression patterns observed with FAM83H variants .

What are the technical considerations for studying FAM83H localization at the keratin cytoskeleton?

FAM83H shows preferential localization to keratin filaments, particularly around the nucleus and extending to cell-cell junctions . For accurate assessment of this localization pattern:

• Sample preparation

  • Use mild fixation protocols that preserve cytoskeletal architecture

  • Consider comparing different fixatives (PFA vs. methanol) as they may reveal different aspects of FAM83H-keratin association

• Co-localization studies

  • Perform dual immunofluorescence with keratin markers

  • Use high-resolution imaging (confocal or super-resolution microscopy)

  • Employ quantitative co-localization analysis (Pearson's coefficient, Manders' overlap)

• Functional disruption approaches

  • Use cytoskeletal disrupting agents (e.g., nocodazole, cytochalasin D) to assess dependence on intact cytoskeleton

  • Compare wild-type vs. mutant FAM83H localization patterns

  • Implement casein kinase I inhibition with D4476 to evaluate the role of this interaction in cytoskeletal association

• Biochemical fractionation

  • Perform subcellular fractionation to separate cytoskeletal and soluble fractions

  • Confirm localization patterns observed by microscopy with biochemical evidence

• Dynamic studies

  • Consider live-cell imaging with fluorescently tagged FAM83H to observe real-time association with keratin filaments

  • FRAP (Fluorescence Recovery After Photobleaching) analysis to assess dynamics of association

These methodological considerations ensure accurate characterization of FAM83H association with the keratin cytoskeleton, which is critical for understanding its function in normal and disease states .

How should researchers approach studying incomplete penetrance in FAM83H-associated amelogenesis imperfecta?

The observation that FAM83H mutations can exhibit incomplete penetrance (carriers may be asymptomatic) introduces significant complexity to genotype-phenotype correlation studies. To investigate this phenomenon:

• Comprehensive phenotyping

  • Develop standardized, quantitative phenotyping methods for enamel defects

  • Document subclinical manifestations that might be overlooked in standard examinations

  • Consider micro-CT analysis for detailed enamel structure assessment

• Extended family studies

  • Screen multiple family members carrying the same FAM83H variant

  • Document phenotypic variability within families

  • Collect detailed medical history to identify potential modifying factors

• Molecular analyses

  • Assess allele-specific expression to detect potential compensatory mechanisms

  • Evaluate expression of potential genetic modifiers in dental tissues

  • Consider whole genome/exome sequencing to identify additional variants that might influence penetrance

• Functional characterization

  • Compare cellular phenotypes (protein localization, keratin organization) between symptomatic and asymptomatic carriers

  • Develop patient-derived cellular models (e.g., iPSCs differentiated toward ameloblast lineage)

  • Utilize CRISPR-Cas9 to introduce identical mutations in consistent genetic backgrounds to isolate the effect of the FAM83H variant

• Environmental assessment

  • Document environmental factors that might influence enamel development

  • Consider gene-environment interactions that could modify disease expression

This multi-faceted approach can help elucidate the mechanisms underlying incomplete penetrance in FAM83H-associated amelogenesis imperfecta, potentially revealing novel insights into enamel formation processes .

How should researchers interpret unexpected band patterns in Western blots using FAM83H antibodies?

When encountering unexpected band patterns in FAM83H Western blots (beyond the predicted 127 kDa band) , consider these methodological approaches to interpretation:

• Multiple band patterns

  • Post-translational modifications: Assess phosphorylation status using phosphatase treatment prior to Western blot

  • Proteolytic processing: Use protease inhibitor cocktails during sample preparation

  • Alternative splicing: Compare with known transcript variants and design isoform-specific primers for RT-PCR validation

  • Cross-reactivity: Test multiple antibodies targeting different epitopes of FAM83H

• Size discrepancies

  • For larger-than-expected bands: Evaluate potential SUMOylation, ubiquitination, or glycosylation

  • For smaller-than-expected bands: Consider truncation mutations, alternative start sites, or proteolytic fragments

  • Compare observed bands with known mutation-specific fragments (particularly relevant in amelogenesis imperfecta studies)

• Validation approaches

  • Peptide competition assays to confirm specificity

  • Knockdown/knockout samples as negative controls

  • Overexpression of tagged FAM83H to confirm band identity

  • Mass spectrometry analysis of immunoprecipitated proteins

• Technical considerations

  • Sample preparation: Use strong denaturing conditions (8M urea) for heavily insoluble or aggregation-prone mutants

  • Transfer efficiency: Extend transfer time for high molecular weight proteins

  • Loading controls: Ensure appropriate controls for cellular compartment of interest

Through systematic analysis and validation, unexpected band patterns can provide valuable insights into FAM83H biology rather than being dismissed as technical artifacts .

What factors contribute to variability in FAM83H subcellular localization patterns?

FAM83H exhibits complex subcellular localization patterns that can vary between wild-type (typically cytoplasmic) and mutant (often nuclear) forms . To understand this variability:

• Experimental factors affecting localization results

  • Fixation method: Compare paraformaldehyde vs. methanol fixation

  • Cell confluence: Examine localization at different cell densities (sparse vs. confluent)

  • Cell type differences: Compare epithelial vs. non-epithelial cells

  • Expression level: Compare endogenous vs. overexpressed protein (potential artifacts from overexpression)

• Biological factors influencing localization

  • Cell cycle stage: Synchronize cells and analyze FAM83H throughout the cell cycle

  • Differentiation status: Compare undifferentiated vs. differentiated cells

  • Keratin expression pattern: Correlate with specific keratin isoforms expressed

  • Casein kinase I activity: Modulate with inhibitors (D4476) or activators

• Mutation-specific effects

  • Truncation location: Map critical regions for localization using deletion constructs

  • Nuclear localization/export signals: Analyze sequence for potential regulatory elements

  • Protein-protein interaction domains: Evaluate how mutations affect binding to cytoskeletal components

• Methodological considerations

  • Use both biochemical fractionation and microscopy approaches

  • Employ live-cell imaging when possible to avoid fixation artifacts

  • Consider super-resolution microscopy for detailed localization patterns

Understanding these variables is crucial for consistent interpretation of FAM83H localization data and its implications for normal function and disease mechanisms .

How can researchers reconcile contradictory findings about FAM83H function in different experimental systems?

The literature contains some apparently contradictory findings regarding FAM83H function across different experimental systems. To reconcile these differences:

• Systematic comparison methodology

  • Create a standardized experimental pipeline to test FAM83H function across multiple systems

  • Document all experimental variables (cell types, expression levels, mutation types)

  • Perform parallel experiments in multiple cell lines relevant to FAM83H biology (ameloblasts, epithelial cells)

• Context-dependent function analysis

  • Evaluate FAM83H function in relation to differentiation state

  • Assess interdependence with tissue-specific factors

  • Map domain-specific functions using truncation/deletion constructs

  • Investigate cell-type specific binding partners through IP-MS approaches

• Technical reconciliation approaches

  • Standardize antibody concentrations and validation protocols

  • Compare endogenous vs. overexpression systems

  • Evaluate acute vs. chronic manipulation of FAM83H levels

  • Assess potential compensatory mechanisms in long-term studies

• Integrated data analysis

  • Combine results from multiple methodologies (genetic, biochemical, imaging)

  • Weight evidence based on methodological rigor

  • Consider evolutionary conservation of observed functions

  • Develop unifying models that accommodate seemingly contradictory findings

• Experimental design for resolution

  • Design experiments specifically to test competing hypotheses

  • Use rescue experiments to confirm specificity of observed phenotypes

  • Implement CRISPR-Cas9 genome editing for precise genetic manipulation

  • Consider three-dimensional culture systems that better recapitulate in vivo conditions

This structured approach helps integrate diverse findings into a coherent understanding of FAM83H biology across experimental contexts .

What are the methodological considerations for studying FAM83H in relation to incomplete penetrance of amelogenesis imperfecta?

The discovery that FAM83H mutations can exhibit incomplete penetrance in amelogenesis imperfecta opens important research directions. Methodologically:

• Genetic modifier identification

  • Perform whole genome sequencing on symptomatic vs. asymptomatic carriers

  • Conduct linkage analysis in extended families with variable expressivity

  • Develop polygenic risk scores incorporating potential modifier variants

  • Consider epigenetic profiling to identify regulatory differences

• Expression modulation studies

  • Analyze allele-specific expression of FAM83H and related genes

  • Evaluate compensatory upregulation of functionally related proteins

  • Assess nonsense-mediated decay efficiency for truncating mutations

  • Measure the ratio of wild-type to mutant protein in different individuals

• Functional characterization approaches

  • Compare protein localization patterns between symptomatic and asymptomatic carriers

  • Assess binding efficiency to casein kinase I and other partners

  • Evaluate impact on keratin cytoskeleton organization

  • Measure effects on desmosome formation and stability

• Model systems development

  • Generate isogenic cell lines with identical FAM83H mutations

  • Develop mouse models with conditional expression of mutant FAM83H

  • Utilize patient-derived iPSCs differentiated toward ameloblast lineage

  • Implement organoid models of tooth development

This multi-faceted approach can help elucidate mechanisms of incomplete penetrance, potentially revealing novel therapeutic targets for amelogenesis imperfecta .

How should researchers design experiments to investigate the relationship between FAM83H and casein kinase I in cytoskeletal regulation?

The interaction between FAM83H and casein kinase I (CK-1) appears critical for keratin cytoskeleton regulation . To investigate this relationship:

• Interaction mapping

  • Define precise binding domains through co-immunoprecipitation of deletion constructs

  • Quantify binding affinity using purified proteins (SPR, ITC)

  • Determine spatial proximity in cells using proximity ligation assays

  • Assess dynamics of interaction through FRET-based biosensors

• Functional disruption approaches

  • Use CK-1 inhibitors (D4476) at varying concentrations and treatment durations

  • Generate FAM83H mutants specifically defective in CK-1 binding

  • Implement CRISPR-Cas9 editing of endogenous FAM83H CK-1 binding sites

  • Develop competing peptides that disrupt the FAM83H-CK-1 interaction

• Substrate identification

  • Perform phosphoproteomic analysis following FAM83H/CK-1 manipulation

  • Map phosphorylation sites on keratin filament components

  • Develop phospho-specific antibodies to monitor key modifications

  • Create phosphomimetic and phospho-deficient mutants of identified substrates

• Cytoskeletal dynamics assessment

  • Utilize live-cell imaging of fluorescently tagged keratin

  • Measure keratin filament turnover rates via FRAP analysis

  • Quantify mechanical properties of the cytoskeleton (atomic force microscopy)

  • Assess cellular response to mechanical stress with/without functional FAM83H-CK-1 interaction

• Developmental context

  • Evaluate temporal regulation during ameloblast differentiation

  • Compare with other epithelial differentiation models

  • Assess conservation across species and tissue types

These methodological approaches will help elucidate the molecular mechanisms by which FAM83H and CK-1 cooperatively regulate cytoskeletal organization in normal development and disease states .

What methodologies are recommended for investigating the potential roles of FAM83H beyond amelogenesis and cytoskeletal regulation?

While FAM83H is well-studied in the context of dental enamel formation and cytoskeletal regulation, broader functions remain to be fully elucidated. To investigate potential additional roles:

• Comprehensive expression profiling

  • Analyze single-cell RNA-seq datasets across tissues and developmental stages

  • Perform immunohistochemical surveys of tissues beyond dental structures

  • Quantify expression in response to various physiological stimuli

  • Compare expression patterns across species to identify conserved functions

• Interactome mapping

  • Conduct unbiased protein-protein interaction screens (BioID, IP-MS)

  • Validate key interactions through orthogonal methods

  • Perform domain-specific interaction studies

  • Develop network models integrating FAM83H with related cellular pathways

• Loss-of-function studies in diverse contexts

  • Generate conditional knockout models to avoid developmental lethality

  • Implement tissue-specific gene targeting approaches

  • Use acute protein degradation technologies (e.g., dTAG system)

  • Apply CRISPR screening to identify context-dependent sensitivities

• Pathological correlations

  • Analyze FAM83H expression/mutation in disease databases beyond amelogenesis imperfecta

  • Evaluate contribution to epithelial disorders and cancers

  • Perform association studies with epithelial differentiation abnormalities

  • Consider potential links to cell migration disorders based on cytoskeletal functions

• Evolutionary analyses

  • Compare FAM83H structure and function across evolutionary distant species

  • Identify conserved vs. divergent domains and functions

  • Reconstruct evolutionary history of the FAM83 protein family

  • Correlate functional innovations with morphological adaptations

These methodological approaches may reveal novel functions of FAM83H in diverse biological contexts, expanding our understanding beyond its established roles in amelogenesis and cytoskeletal regulation .